title: WISE 2005: vascular responses to 60-day bed rest in women.
abstract: WISE-2005 studied 24 women during a 60-day head down bed rest (HDBR) who look part in an exercise countermeasure (LBNP-treadmill plus flywheel, EX) and no-exercise (No-EX). We conducted a series of experiments to explore changes in cardiovascular function and the ability of EX to prevent these changes. Resting arterial diameter in the arm was not affected but the leg arteries (femoral and popliteal) were significantly reduced in Np-EX, but was increased in EX. In this study we report on drug stimulated responses with sublingual nitroglycerin and infused isoproterenol. Heart rate increased in response to nitroglycerin with larger increases in No-EX after HDBR. Likewise during isoproterenol infusion the HR increase was greater after HDBR in the No-EX group. In all cases, the higher HR was associated with lower stroke volume in No-EX while stroke volume was protected in EX. These data do not support a change in sensitivity of beta-adrenergic receptors after HDBR. The leg vascular resistance decreased in response to isoproterenol and it decreased to a greater extent in No-EX than EX. These data were consistent with observations of lower leg vascular resistance during orthostatic challenge tests after HDBR. We conclude that consistent changes in cardiovascular function in the No-EX were detected by different methods that point to mechanisms contributing to orthostatic intolerance after HDBR.
authors: Cardiorespiratory & Vascular Dynamics Lab, Univ. Waterloo, Waterloo, Ontario, Canada. hughson@uwaterloo.ca
authors: R L
authors: RL
authors: Hughson
authors: J K
authors: JK
authors: Shoemaker
authors: Ph
authors: P
authors: Arbeille
authors: K S
authors: KS
authors: Dyson
authors: H
authors: H
authors: Edgell
authors: P
authors: P
authors: Kerbeci
authors: L
authors: L
authors: Mattar
authors: K
authors: K
authors: Zuj
authors: D K
authors: DK
authors: Greaves
mesh_terms: D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000328:Adult; D001510:Bed Rest / Q000009:adverse effects*; D002302:Cardiac Output; D018493:Cardiovascular Deconditioning; D004044:Dietary Proteins / Q000008:administration & dosage; D004244:Dizziness / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D015444:Exercise; D005260:Female; D005263:Femoral Artery / Q000187:drug effects / Q000503:physiopathology*; D018475:Head-Down Tilt / Q000009:adverse effects; D006339:Heart Rate; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage; D008150:Lower Body Negative Pressure; D005996:Nitroglycerin / Q000008:administration & dosage; D011150:Popliteal Artery / Q000187:drug effects / Q000503:physiopathology*; D013026:Space Flight; D013318:Stroke Volume; D013997:Time Factors; D014655:Vascular Resistance; D014665:Vasodilator Agents / Q000008:administration & dosage; D018544:Weightlessness Countermeasures; D018474:Weightlessness Simulation
chemical_list: D000318:Adrenergic beta-Agonists; D004044:Dietary Proteins; D014665:Vasodilator Agents; D005996:Nitroglycerin; D007545:Isoproterenol